中华医学杂志（英文版）2022，Vol.135Issue(4)：409-415,7.DOI:10.1097/CM9.0000000000001948
Risk of tuberculosis in patients with rheumatoid arthritis treated with biological and targeted drugs:meta-analysis of randomized clinical trials
Risk of tuberculosis in patients with rheumatoid arthritis treated with biological and targeted drugs:meta-analysis of randomized clinical trials
Xiaojian Ji 1Feng Huang 1Lidong Hu 2Yiwen Wang 1Siliang Man 1Xingkang Liu 1Chuan Song 1Jiaxin Zhang 1Jian Zhu 1Jianglin Zhang1
作者信息
- 1. Department of Rheumatology and Immunology,The First Medical Center,Chinese PLA General Hospital,Beijing 100853,China
- 2. Xiamen Key Laboratory of Translational Medicine for Nucleic Acid Metabolism and Regulation,Xiang'an Hospital of Xiamen University,Xiamen,Fujian 361102,China
- 折叠
摘要
关键词
Rheumatoid arthritis/Biological therapy/Tuberculosis/Systematic review/Meta-analysis/Network meta-analysisKey words
Rheumatoid arthritis/Biological therapy/Tuberculosis/Systematic review/Meta-analysis/Network meta-analysis引用本文复制引用
Xiaojian Ji,Feng Huang,Lidong Hu,Yiwen Wang,Siliang Man,Xingkang Liu,Chuan Song,Jiaxin Zhang,Jian Zhu,Jianglin Zhang..Risk of tuberculosis in patients with rheumatoid arthritis treated with biological and targeted drugs:meta-analysis of randomized clinical trials[J].中华医学杂志（英文版）,2022,135(4):409-415,7.
